发明名称 LYOPHILIZED VIRAL FORMULATIONS
摘要 Provided herein are lyophilized viral formulations useful for the stabilization and storage of viruses and methods of preparing these formulations. The lyophilized viral formulations described herein include a virus (e.g., a purified virus) and a non-viral composition including excipients. The formulations can be used, for example, to retain the infectivity or immunogenicity of viruses during periods of storage.
申请公布号 US2015224198(A1) 申请公布日期 2015.08.13
申请号 US201514693100 申请日期 2015.04.22
申请人 Oncolytics Biotech Inc. 发明人 Coffey Matthew C.;Serl Sarah;Pavliv Leo
分类号 A61K47/26;C12N7/00;A61K47/02;A61K35/765 主分类号 A61K47/26
代理机构 代理人
主权项 1. A viral formulation, comprising: (a) a purified virus; and (b) a non-viral composition comprising: (i) sucrose;(ii) Mg2+; and(iii) a non-ionic surfactant, wherein the viral formulation is lyophilized; wherein the non-viral composition, prior to lyophilization, is a liquid non-viral composition further comprising a liquid carrier; wherein the concentration of sucrose in the liquid non-viral composition, prior to lyophilization, is less than 5% based on the weight of the liquid non-viral composition; wherein the liquid non-viral composition, excluding the liquid carrier, is substantially free of monovalent cationic salts, non-sucrose polyols, and carboxylates; and wherein the non-viral composition is provided in an amount effective to stabilize the purified virus.
地址 Calgary CA